Oct 20 2009
To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, (NASDAQ:ECLP), The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today. With a client base that leads the industry in adoption of computerized physician order entry (CPOE), outperforms peers in composite performance across all Centers for Medicare and Medicaid Services (CMS) Quality Measures and clinical information systems that dominate the Magnet Recognition Program® hospitals, Eclipsys offers an industry-differentiating ability to support healthcare providers in meeting the expected “meaningful use” objectives of the American Recovery and Reinvestment Act (ARRA). In addition, the company’s analytics technology provides a solid foundation to meet the expected more stringent and outcomes-focused ARRA requirements in 2013 and 2015.
A Client Base Ranked No. 1 in Meeting Composite CMS Quality Measures; Dominates Magnet Hospitals
In conducting a competitive analysis study of CMS Core Measures performance, data identified Eclipsys clients as ranking No. 1 in composite performance across all CMS Quality Measures. The study, which was based on publicly available data from HIMSS Analytics and the U.S. Department of Health and Human Services Hospital Compare site, also identified that Eclipsys clients ranked No. 1 in adherence to surgery CMS criteria, while statistically tying in adherence to heart failure, acute myocardial infarction (AMI) and pneumonia.
According to Jay Deady, Eclipsys executive vice president of Client Solutions, Eclipsys clients’ superior quality outcomes are a factor of the advanced clinical decision support and embedded complex algorithms built into the company’s CPOE solution, which leverage more than 30 years of experience to transcend fundamental computerized order entry. “Proactive, advanced clinical decision support is going to be a critical success factor in meeting ARRA ‘meaningful use’ requirements,” said Deady. “The fact that our client base today is comprised of higher-performing organizations is a clear demonstration of what sets apart Eclipsys in helping healthcare organizations improve patient health status and outcomes, the fundamental goal behind this government act. With hundreds of healthcare organizations seeking a new clinical information system platform, we expect our proven track record and strong positioning to support us in achieving expanded market share.”
Industry CPOE Adoption Leadership
A key provision of ARRA is that healthcare organizations must drive the use of information technology to improve patient health status — not just demonstrate its existence or specific functionality. According to the KLAS CPOE Digest 2009: Meaningful Use and Physician Adoption report, deep adoption is pivotal to the overarching success of an electronic medical record (EMR) implementation. The same KLAS report concludes that Eclipsys leads the industry in total physicians live on CPOE and percentage of its client base using the system. Eclipsys also continues to have the highest physician satisfaction from clients who use its system, and on average, highly customizable ordering capabilities allow a physician to order faster than any other CPOE solution on the market.
In addition, Eclipsys’ clinical information systems dominate the field of Magnet Recognition Program® hospitals. Magnet status provides consumers with a benchmark to measure the quality of care they can expect to receive. Eclipsys clients represent 45 percent of all organizations receiving Magnet status, and represent 40 percent of the organizations listed as “America’s Best Hospitals,” according to the U.S. News & World Report’s 2009 ranking.
ARRA Requirement to Use Clinical Data in More Meaningful Ways
Along with the existing rise in pay-for-performance and changes in reimbursements, ARRA is expected to require healthcare organizations to use patient data to drive insight and intelligence about how systems and practice patterns are affecting care quality and outcomes. With the addition of the Sunrise Clinical Analytics™ business intelligence solution to what is slated to be Eclipsys’ ARRA 2011 Certified EHR (electronic health record) Technology, Eclipsys plans to offer hospitals unparalleled capabilities to meet increasingly complex quality reporting requirements. Sunrise Clinical Analytics intelligently extracts and transforms data at the right time from Eclipsys’ Sunrise Clinical Manager™ electronic health record solution to automate quality reporting. Ease of access to information is delivered without disruption to clinical workflows. The analytics system is designed to support organizations in effectively tracking and measuring clinical performance and identifying how clinician adoption impacts patient outcomes and clinical costs.
“We believe no other health information technology company can match our proven record of deep clinical adoption, our system agility to respond to changing environments and requirements and an unparalleled integrated clinical analytics solution,” added Deady. “Providers seeking to prepare for the implications of this momentous legislation should have confidence in selecting Eclipsys as their clinical technology partner.”
Eclipsys’ CPOE high adoption rates and speed are a factor of its embedded complex algorithms that leverage more than 30 years of experience to transcend fundamental order entry and offer a solution that is able to automatically interpret and recalculate new order protocols in real time based on any updates to the patient condition. The intuitive, easy-to-adopt solution offers highly complex clinical decision support capabilities that provide workflows tailored to how physician’s practice medicine and support fully automating even the most complex order sets and medication ordering, including the exacting protocols, long-range medication schedules and complicated treatment plans commonplace in oncology and pediatric care environments.